The Plastic Surgery Foundation and MTI Biologics announced that applications are now being accepted for their Allograft Tissue Research Grant. According to the companies’ joint news release, the program, which began in 2013, funds advancements in tissue transplantation to enhance patient care.
“To develop new clinical approaches and advance positive patient outcomes in plastic and reconstructive surgery, we need a constant stream of new research in the field,” said Arun Gosain, M.D., president, The Plastic Surgery Foundation. “We are pleased to continue this partnership with MTF Biologics to fund the critical work of clinicians and scientists seeking to uncover new ways that human tissue can advance patient care and results.”
Selected applicants may receive up to $100,000 to support one- to two-year research projects, which must include a strong clinical translation component that incorporates dermal, adipose, placental or other allograft transplant technologies, the companies say.
Previously funded projects have examined such topics as the use of adipose stem cells for the prevention and treatment of diabetic foot ulcers, the impact of adipose derived stem cells on skin improvement in radiation wounds, and tissue-engineered lymph node transplantation for the treatment of lymphedema, as examples.
Applications for the 2019 PSF/MTF Allograft Tissue Research Grant Program will be accepted through December 3, 2018. For more information or to apply, visit www.thepsf.org.
